Regeneron Pharmaceuticals, INC lobbies on its own behalf. For Q3 2026 it reported $590K across 1 client report and lists 3 lobbyists across its filings. Issues include Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid and Taxation/Internal Revenue Code.
| Client | Reported | Issues |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC | $590K | Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.86M | 1 |
| 2025 | $2.19M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.